Plain-English translation of NCT03762395 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a medication called can help people with asthma who also struggle with obesity. Extra weight can make asthma worse by causing inflammation in the body and lungs. This study will see if the medication can reduce that inflammation and make airways less sensitive and reactive.
Asthma is often more severe in people who are overweight or obese because extra weight triggers chronic inflammation throughout the body. Researchers believe this medication might work by calming that inflammation, which could ease asthma symptoms that don't respond well to standard treatments alone.
You likely qualify if…
You likely don't qualify if…
You will visit the study site several times over about 4 months. You will take a daily pill for 6 weeks—either the new medication or a placebo (a pill with no active ingredient). After a 4-week break where you take nothing, you will then take the other pill (whichever you didn't take first) for another 6 weeks. Throughout the study, your asthma symptoms, lung function, and inflammation levels will be measured to see if the medication helps reduce how reactive your airways are.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States